Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 273

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Polyethylene glycol–superoxide dismutase, a conjugate in search of exploitation

Veronese, Francesco M., Caliceti, Paolo, Schiavon, Oddone, Sergi, Mauro·2002·Advanced Drug Delivery Reviews

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0169-409x(02)00029-7

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 180

  1. Varani, 1994, Mechanisms of endothelial cell injury in acute inflammation, Stroke, 2, 311
  2. Heffner, 1989, Pulmonaty strategies of antioxidant defense, Am. Rev. Respir. Dis., 140, 531, 10.1164/ajrccm/140.2.531 · DOI · Paper page
  3. Siflingerbirnboim, 1993, Neutrophil adhesion to endothelial cells impairs the effects of catalase and glutathione in preventing endothelial injury, J. Cell. Physiol., 155, 234, 10.1002/jcp.1041550203 · doi:10.1002/jcp.1041550203
  4. Freeman, 1987, Free radicals and tissue injury, Lab. Invest., 47, 412
  5. Mossman, 1986, Approaches to prevention of asbestos-induced lung disease using polyethylene glycol (PEG)-conjugated catalase, Free Radic. Biol. Med., 2, 335, 10.1016/S0748-5514(86)80033-2 · DOI
  6. Edsmyr, 1976, Orgotein efficacy in ameliorating side effects due to radiation therapy: double-blind, placebo-controlled trial in patients with bladder tumors, Curr. Ther. Res., 19, 198
  7. Tetsuo, 1966, Effect of superoxide dismutase on glomerular nephritis, Biochem. Pharmacol., 35, 341, 10.1016/0006-2952(86)90536-8 · doi:10.1016/0006-2952(86)90536-8
  8. Barman, 1969, Vol. 1, 232
  9. Lund-Olesen, 1974, Orgotein: a new anti-inflammatory metalloprotein drug: preliminary evaluation of clinical efficacy and safety in degenerative joint disease, Curr. Ther. Res., 7, 706
  10. Goebel, 1983, Effect of intra-articular orgotein versus a corticosteroid on rheumatoid arthritis of the knee, Am. J. Med., 74, 124, 10.1016/0002-9343(83)91128-2 · DOI
  11. Marberger, 1974, Orgotein: a new anti-inflammatory metalloprotein drug evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract, Int. Urol. Nephrol., 6, 61, 10.1007/BF02081999 · DOI
  12. Greenwald, 1985, Therapeutic benefits of oxygen radical scavenger treatments remain unproven, Free Rad. Biol. Med., 1, 173, 10.1016/0748-5514(85)90115-1 · DOI
  13. Giri, 1984, Fate of superoxide dismutase in mice following oral route of administration, Med. Biol., 62, 285
  14. Koyama, 1992, Recombinant-human superoxide dismutase attenuates endotoxin-induced lung injury in awake sheep, Am. Rev. Respir. Dis., 145, 1404, 10.1164/ajrccm/145.6.1404 · DOI
  15. Shaffer, 1987, Administration of bovine superoxide dismutase fails to prevent chronic pulmonary sequelae of neonatal oxygen exposure in the rat, J. Pediatr., 110, 942, 10.1016/S0022-3476(87)80419-5 · DOI
  16. Garcia, 1995, Effect of CuZnSOD on endothelium-dependent vasodilation in patients with essential hypertension, Hypertension, 26, 863, 10.1161/01.HYP.26.6.863 · DOI
  17. Carpenter, 2001, Superoxide dismutase and catalase do not affect the pulmonary hypertensive response to group B Streptococcus in the lamb, Pediatric Res., 49, 181, 10.1203/00006450-200102000-00009 · doi:10.1203/00006450-200102000-00009
  18. Abuchowski, 1977, J. Biol. Chem., 252, 3578, 10.1016/S0021-9258(17)40291-2 · DOI · Paper page
  19. Monfardini, 1998, Stabilization of substances in circulation, Bioconjugate Chem., 9, 418, 10.1021/bc970184f · DOI
  20. P. Caliceti, F.M. Veronese, Effect of peptide and protein PEGylation on pharmacokinetics and biodistribution, this journal issue on pegylation, second part (to be published).
  21. Greenwald, 1986, Treatment of inflammatory arthritis with oxygen radical scavengers, Free Rad. Biol. Med., 2, 367, 10.1016/S0748-5514(86)80037-X · doi:10.1016/s0748-5514(86)80037-x
  22. Viau, 1986, Safety evaluation of free radical scavengers PEG–catalase and PEG–superoxide dismutase, Free Rad. Biol. Med., 2, 283, 10.1016/S0748-5514(86)80011-3 · DOI
  23. Turrens, 1984, Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase, J. Clin. Invest., 73, 87, 10.1172/JCI111210 · DOI · Paper page
  24. Freeman, 1985, Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase, Fed. Proc., Fed. Am. Soc. Exp. Biol., 44, 2591
  25. Pradmanabhan, 1985, Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase, Am. Rev. Respir. Dis., 132, 164
  26. Michelson, 1985, La superoxyde dismutase et la pathologie des radicaux libres, C.R. Soc. Biol., 179, 429
  27. McDonald, 1985, Effects of superoxide dismutase encapsulated in liposomes or conjugated with polyethylene glycol on neutrophils bactericidal activity in vitro and bacterial clearance in vivo, Am. Rev. Respir. Dis., 13, 633, 10.1164/arrd.1985.131.4.633 · DOI
  28. Freeman, 1983, Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury, J. Biol. Chem., 258, 12534, 10.1016/S0021-9258(17)44209-8 · DOI · Paper page
  29. Yusa, 1984, Liposome-mediated augmentation of brain SOD and catalase inhibits CNS O2 toxicity, J. Appl. Physiol., 57, 1674, 10.1152/jappl.1984.57.6.1674 · DOI
  30. Nakae, 1990, Endocytosis-independent uptake of liposome-encapsulated superoxide dismutase prevents the killing of cultured hepatocytes by tert-butyl hydroperoxide, Arch. Biochem. Biophys., 279, 315, 10.1016/0003-9861(90)90497-M · doi:10.1016/0003-9861(90)90497-m
  31. Regnault, 1995, Effect of encapsulation in liposomes on the anti-inflammatory properties of superoxide dismutase after oral administration, Clin. Chim. Acta, 240, 117, 10.1016/0009-8981(95)06133-X · DOI
  32. Nakae, 1990, Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen, Am. J. Pathol., 136, 787
  33. Corvo, 1999, Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis, Biochim. Biophys. Acta, 1419, 325, 10.1016/S0005-2736(99)00081-4 · DOI
  34. Fujita, 1992, Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion, Biochem. Biophys. Res. Commun., 189, 191, 10.1016/0006-291X(92)91543-Y · DOI
  35. Maksimenko, 1992, Effect of native and modified forms of superoxide dismutase and catalase on experimental silicosis in rats, Ann. N.Y. Acad. Sci., 672, 118, 10.1111/j.1749-6632.1992.tb35612.x · doi:10.1111/j.1749-6632.1992.tb35612.x
  36. Maksimenko, 1995, Biodistribution of a polyethylene glycol-modified superoxide dismutase in mice and its effect on myocardial ischemia treatment in rats, Drug Deliv., 2, 39, 10.3109/10717549509031349 · doi:10.3109/10717549509031349
  37. Caliceti, 1995, Physico-chemical and biological properties of monofunctional hydroxy terminating poly(N-vinyl pyrrolidone) conjugated superoxide dismutase, J. Bioact. Compat. Polym., 10, 103, 10.1177/088391159501000202 · DOI
  38. Oda, 1989, Oxygen radicals in influenza induced pathogenesis and treatment with pyran polymer-conjugated SOD, Science, 244, 974, 10.1126/science.2543070 · DOI · Paper page
  39. Hirano, 1994, Synthesis of the conjugate of superoxide dismutase with the copolymer of divinyl ether and maleic anhydride retaining enzymatic activity, J. Controlled Release, 28, 203, 10.1016/0168-3659(94)90167-8 · DOI
  40. Caliceti, 1996, Modification of physico-chemical and biopharmaceutical properties of superoxide dismutase by conjugation to the copolymer of divinyl ether and maleic anhydride, J. Controlled Release, 39, 27, 10.1016/0168-3659(95)00130-1 · doi:10.1016/0168-3659(95)00130-1
  41. Wong, 1980, Enhanced anti-inflammatory effects and reduced immunogenicity of bovine liver superoxide dismutase by conjugation with homologous albumin, Agent Actions, 10, 231, 10.1007/BF02025941 · doi:10.1007/bf02025941
  42. Yamazaki, 1997, Effect of lecithinized-superoxide dismutase on the interstitial pneumonia model induced by bleomycin in mice, Jpn. J. Pharmacol., 75, 97, 10.1254/jjp.75.97 · DOI
  43. Nakamura, 1999, Lecithinized superoxide dismutase induces vasodilation: evidence of direct contribution of superoxide anions to modulating vascular tone, Life Sci., 64, 65, 10.1016/S0024-3205(98)00564-5 · doi:10.1016/s0024-3205(98)00564-5
  44. Miyahara, 1998, Lecithinized superoxide dismutase attenuates phorbol myristate acetate-induced injury in isolated dog lung, Eur. J. Pharmacol., 344, 231, 10.1016/S0014-2999(97)01609-9 · doi:10.1016/s0014-2999(97)01609-9
  45. Takenaga, 1999, Effect of lecithinized superoxide dismutase (PC–SOD) on experimental pulmonary metastasis in mice, Free Radic. Biol. Med., 26, 1117, 10.1016/S0891-5849(98)00301-3 · doi:10.1016/s0891-5849(98)00301-3
  46. Abuchowski, 1977, Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase, J. Biol. Chem., 252, 3582, 10.1016/S0021-9258(17)40292-4 · DOI · Paper page
  47. Pyatak, 1980, Preparation of a polyethylene glycol: superoxide dismutase adduct, and an examination of its blood circulating life and anti-inflammatory activity, Res. Commun. Chem. Pathol. Pharmacol., 29, 113
  48. Beauchamp, 1983, A new procedure for the synthesis of polyethylene glycol-protein adducts: effects on function, receptor recognition and clearance of superoxide dismutase, lactoferrin and b-2-macroglobulin, Anal. Biochem., 131, 25, 10.1016/0003-2697(83)90131-8 · DOI · Paper page
  49. Veronese, 1985, Surface modification of proteins: activation of monomethoxy-polyethylene glycol by phenylchloroformates and modification of ribonuclease and superoxide dismutase, Appl. Biochem. Biotechnol., 11, 141, 10.1007/BF02798546 · DOI · Paper page
  50. Conforti, 1987, PEG superoxide dismutase derivatives: anti-inflammatory activity in carrageenan pleurisy in rats, Pharmacol. Res. Commun., 19, 187, 10.1016/0031-6989(87)90086-5 · doi:10.1016/0031-6989(87)90086-5
  51. Nucci, 1986, Immunogenicity of polyethylene glycol-modified superoxide dismutase and catalase, Free Rad. Biol. Med., 2, 321, 10.1016/S0748-5514(86)80031-9 · DOI
  52. Veronese, 1983, Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters, J. Pharmacol., 35, 757, 10.1111/j.2042-7158.1983.tb02888.x · DOI
  53. Saifer, 1994, Plasma clearance and immunologic properties of long-acting superoxide dismutase prepared using 35,000 to 120,000 dalton polyethylene glycol, Adv. Exp. Med. Biol., 366, 377, 10.1007/978-1-4615-1833-4_26 · doi:10.1007/978-1-4615-1833-4_26
  54. Beckman, 1986, Augmentation of antioxidant enzymes in vascular endothelium, Free Radic. Biol. Med., 2, 359, 10.1016/S0748-5514(86)80036-8 · DOI
  55. Walther, 1990, Mitigation of pulmonary oxygen toxicity in premature lambs with intravenous antioxidants, Exp. Lung. Res., 16, 177, 10.3109/01902149009108839 · DOI
  56. Beckman, 1988, Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance, J. Biol. Chem., 263, 6884, 10.1016/S0021-9258(18)68727-7 · DOI · Paper page
  57. Mihara, 1994, Improvement of therapeutic effect of human recombinant superoxide dismutase on ischaemic acute renal failure in the rat via cationization and conjugation with polyethylene glycol, J. Drug Target., 2, 317, 10.3109/10611869409015912 · doi:10.3109/10611869409015912
  58. Caliceti, 1989, Evaluation of monomethoxypolyethyleneglycol derivatized superoxide dismutase in blood and evidence for its binding to blood cells, Il Farmaco, 44, 711
  59. Veronese, 1989, Preparation, physico-chemical and pharmacokinetic characterization of monomethoxypoly(ethylene glycol)-derivatized superoxide dismutase, J. Controlled Release, 10, 145, 10.1016/0168-3659(89)90025-4 · DOI · Paper page
  60. Conforti, 1991, Anti-inflammatory activity of monomethoxypolyethylene glycol superoxide dismutase on adjuvant arthritis in rats, Pharmacol. Res., 23, 51, 10.1016/S1043-6618(05)80106-9 · doi:10.1016/s1043-6618(05)80106-9
  61. F.M. Veronese, A. Conforti, G.P. Velo, Superoxide dismutase modifications for anti-inflammatory therapy, in: K.D. Rainsford, G.P. Velo (Eds.), Inflammation and Drug Therapy Series, Vol. III, New Developments in Antirheumatic Therapy, Kluwer Academic Publisher, Dordrecht, Boston, 1989, pp. 305–314. · doi:10.1007/978-94-009-1253-3_12
  62. Lamka, 1995, Distribution of catalase, ribonuclease and superoxide dismutase modified by monomethoxy (polyethylene glycol) into rat central lymph and lymphatic nodes, Physiol. Res., 44, 307
  63. Nguyen, 1999, Polyethylene glycol–superoxide dismutase inhibits lipid peroxidation in hepatic ischemia/reperfusion injury, Crit. Care, 3, 127, 10.1186/cc358 · doi:10.1186/cc358
  64. Banci, 1990, Spectroscopic characterization of polyethyleneglycol superoxide dismutase: 1H NMR studies on its Cu2Co2 derivative, J. Inorg. Biochem., 39, 149, 10.1016/0162-0134(90)80023-Q · DOI
  65. Huynh, 1999, Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts, J. Surg. Res., 84, 223, 10.1006/jsre.1999.5647 · DOI
  66. Winn, 1999, Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity, Free Radic. Biol. Med., 26, 266, 10.1016/S0891-5849(98)00193-2 · DOI
  67. Supinski, 1997, Effect of free radical scavengers on diaphragmatic fatigue, Am. J. Respir. Crit. Care Med., 155, 622, 10.1164/ajrccm.155.2.9032204 · DOI
  68. Yabe, 1999, Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives, J. Pharmacol. Exp. Ther., 289, 1176
  69. Muzykantov, 2001, Targeting of superoxide dismutase and catalase to vascular endothelium, J. Controlled Release, 71, 1, 10.1016/S0168-3659(01)00215-2 · DOI · Paper page
  70. Fujita, 1992, Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives, J. Pharmacol. Exp. Ther., 263, 971
  71. Mihara, 1994, Manipulation of renal disposition of human recombinant superoxide modification, Biol. Pharm. Bull., 17, 296, 10.1248/bpb.17.296 · DOI
  72. Inoue, 1990, Inhibition of oxygen toxicity by targeting superoxide dismutase to endothelial cell surfaces, FEBS Lett., 269, 89, 10.1016/0014-5793(90)81126-9 · DOI
  73. Sandstrom, 1994, 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain, J. Biol. Chem., 269, 19163, 10.1016/S0021-9258(17)32289-5 · DOI · Paper page
  74. Wengenack, 1997, Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia, Brain Res., 754, 46, 10.1016/S0006-8993(97)00041-3 · DOI
  75. Reinholz, 1999, Plasma pharmacokinetics, nervous system biodistribution and biostability, and spinal cord permeability at the blood–brain barrier of putrescine-modified catalase in the adult rat, Exp. Neurol., 159, 191, 10.1006/exnr.1999.7117 · DOI
  76. McCord, 1969, Superoxide dismutase, an enzymatic function for erythrocuprein, J. Biol. Chem., 244, 6049, 10.1016/S0021-9258(18)63504-5 · DOI · Paper page
  77. Huber, 1968, Some chemical and pharmacological properties of a novel anti-inflammatory protein, Toxicol. Appl. Pharmacol., 12, 308
  78. Steinman, 1974, Bovine erythrocyte superoxide dismutase complete amino acid sequence, J. Biol. Chem., 22, 7326, 10.1016/S0021-9258(19)42108-X · DOI
  79. Beem, 1974, Total reconstitution of copper–zinc superoxide dismutase, J. Biol. Chem., 249, 7298, 10.1016/S0021-9258(19)42105-4 · doi:10.1016/s0021-9258(19)42105-4
  80. Desideri, 1981, X-ray absorption edge spectroscopy of Co(II)-binding sites of copper- and zinc-containing proteins, Biochim. Biophys. Acta, 661, 312, 10.1016/0005-2795(81)90102-1 · doi:10.1016/0005-2795(81)90102-1
  81. Banci, 1987, Nuclear relaxation in the magnetic coupled system Cu2Co2SOD. Histidine-44 is detached upon anion binding, J. Am. Chem. Soc., 109, 2328, 10.1021/ja00242a014 · doi:10.1021/ja00242a014
  82. Rigo, 1977, Competitive inhibition of Cu,Zn superoxide dismutase by monovalent anions, Biochem. Biophys. Res. Commun., 79, 776, 10.1016/0006-291X(77)91179-2 · doi:10.1016/0006-291x(77)91179-2
  83. Royer, 1979, Peptide synthesis in water and the use of immobilized carboxypeptidase Y for deprotection, J. Am. Chem. Soc., 101, 3394, 10.1021/ja00506a051 · doi:10.1021/ja00506a051
  84. Buckamann, 1982, Functionalization of poly(ethylene glycol) and monomethoxy-poly(ethylene glycol), Makromol. Chem., 182, 1379, 10.1002/macp.1981.021820509 · doi:10.1002/macp.1981.021820509
  85. Snyder, 1975, An improvement of 2,4,6-trinitrobenzenesulfonic acid method for determination of amines, Anal. Biochem., 64, 284, 10.1016/0003-2697(75)90431-5 · DOI · Paper page
  86. Habeeb, 1966, Determination of free amino groups in proteins by trinitrobenzene-sulfonic acid, Anal. Biochem., 14, 328, 10.1016/0003-2697(66)90275-2 · DOI · Paper page
  87. Udenfriend, 1972, Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range, Science, 178, 871, 10.1126/science.178.4063.871 · DOI · Paper page
  88. Schiavon, 1990, A direct assay for evaluation of polyethylene glycol in enzyme adducts used as drugs or biocatalysts, Farmaco, 45, 791
  89. Sartore, 1991, Accurate evaluation method of the polymer content in monomethoxy(polyethylene glycol) modified proteins based on amino acid analysis, Appl. Biochem. Biotech., 31, 213, 10.1007/BF02921748 · DOI
  90. Bullock, 1997, Comparison of results of various methods used to determine the extent of modification of methoxy polyethylene glycol 500-modified bovine Cu–Zn superoxide dismutase, Anal. Biochem., 254, 254, 10.1006/abio.1997.2405 · doi:10.1006/abio.1997.2405
  91. Snider, 1992, Characterization of the heterogeneicity of polyethylene glycol-modified superoxide dismutase by chromatographic and electrophoretic techniques, J. Chromatogr., 599, 141, 10.1016/0021-9673(92)85467-8 · doi:10.1016/0021-9673(92)85467-8
  92. Zimmerman, 1996, Electrophoresis of polyethylene glycols and related materials as sodium dodecyl sulfate complexes, Anal. Biochem., 234, 190, 10.1006/abio.1996.0071 · DOI
  93. Veronese, 1990, A comparative study of enzymatic, structural and pharmacokinetic properties of superoxide dismutase isolated from two sources and modified by monomethoxypoly(ethylene glycol) using different methods of coupling, Vol. 613, 468
  94. Finlay, 1978, New methods for the preparation of biospecific adsorbents and immobilized enzymes utilizing trichloro-s-triazine, Anal. Biochem., 87, 77, 10.1016/0003-2697(78)90571-7 · DOI
  95. Vestling, 1993, A strategy for characterization of polyethylene glycol-derivatized proteins. A mass spectrophotometric analysis of the attachment site in polyethylene glycol-derivatized superoxide dismutase, Drug Metab. Dispos., 21, 911
  96. Nakaoka, 1997, Prolongation of serum half-life period of superoxide dismutase by poly(ethylene glycol) modification, J. Controlled Release, 46, 253, 10.1016/S0168-3659(96)01605-7 · doi:10.1016/s0168-3659(96)01605-7
  97. Sato, 1995, Synthesis and characterization of superoxide dismutase–deferoxamine conjugate via polyoxyethylene: a new molecular device for removal of a variety of reactive oxygen species, Bioconjug. Chem., 6, 249, 10.1021/bc00033a003 · DOI
  98. Corvo, 2000, Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: in vivo fate and therapeutic activity in an inflammation model, Pharm. Res., 17, 600, 10.1023/A:1007577101964 · doi:10.1023/a:1007577101964
  99. Petkau, 1976, Tissue distribution of bovine 125I-superoxide dismutase in mice, Res. Commun. Chem. Pathol. Pharmacol., 15, 641
  100. Boccù, 1982, Pharmacokinetic properties of polyethylene glycol derivatized superoxide dismutase, Pharmacol. Res. Commun., 14, 113, 10.1016/S0031-6989(82)80092-1 · doi:10.1016/s0031-6989(82)80092-1
  101. Kelly, 2001, Diabetes insipidus in uricase-deficient mice: model for evaluating therapy with poly(ethylene glycol)-modified uricase, J. Am. Soc. Nephrol., 12, 1001, 10.1681/ASN.V1251001 · DOI
  102. Sherman, 1997, Conjugation of high-molecular weight poly(ethylene glycol) to cytokines: granulocyte–macrophage colony-stimulating factors as model substrates, Vol. 680, 155
  103. Somack, 1991, Preparation of long-acting superoxide dismutase using high molecular weight polyethylene glycol (41,000–72,000 daltons), Free Rad. Res. Commun., 12–13, 553, 10.3109/10715769109145830 · DOI
  104. Smith, 1995, Pharmacokinetics and tolerability of ventricularly administered superoxide dismutase in monkeys and preliminary clinical observations in familial ALS, J. Neurol. Sci., 129, 13, 10.1016/0022-510X(95)00051-3 · DOI
  105. Davies, 1980, Enhanced rates of fluid pinocytosis during exponential growth and monolayer regeneration by cultured arterial exponential cells, J. Cell. Physiol., 102, 119, 10.1002/jcp.1041020204 · DOI
  106. Mugge, 1991, Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits, Circ. Res., 69, 1293, 10.1161/01.RES.69.5.1293 · DOI · Paper page
  107. Chappell, 1987, Effect of lipid feeding on endothelium dependent relaxation in rabbit aortic preparations, Cardiovasc. Res., 21, 34, 10.1093/cvr/21.1.34 · DOI
  108. Jayakody, 1988, Impairment of endothelium-dependent relaxation: an early marker for atherosclerosis in the rabbit, Br. J. Pharmacol., 94, 335, 10.1111/j.1476-5381.1988.tb11535.x · DOI
  109. Verbeuren, 1986, Effect of hypercholesterolemia on vascular reactivity in the rabbit, Circ. Res., 58, 552, 10.1161/01.RES.58.4.552 · DOI · Paper page
  110. Freiman, 1986, Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates, Circ. Res., 58, 783, 10.1161/01.RES.58.6.783 · DOI · Paper page
  111. Bossaller, 1987, Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta, J. Clin. Invest., 79, 170, 10.1172/JCI112779 · DOI · Paper page
  112. Forstermann, 1988, Selective attenuation of endothelium-mediated vasodilatation in atherosclerotic human coronary arteries, Circ. Res., 62, 185, 10.1161/01.RES.62.2.185 · DOI · Paper page
  113. Sreeharan, 1986, Endothelium-dependent relaxation and experimental atherosclerosis in the rabbit aorta, Can. J. Physiol. Pharmacol., 64, 1451, 10.1139/y86-246 · DOI
  114. Guerra, 1989, Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: implications for altered autocrine and paracrine functions of EDRF, Blood Vessels, 26, 300
  115. Rubanyi, 1988, Vascular effects of oxygen-derived free radicals, Free Radic. Biol. Med., 4, 107, 10.1016/0891-5849(88)90071-8 · DOI · Paper page
  116. Henning, 1988, Lipid peroxidation and endothelial cell injury: implications in atherosclerosis, Free Radic. Biol. Med., 4, 99, 10.1016/0891-5849(88)90070-6 · DOI · Paper page
  117. Gryglewski, 1986, Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor, Nature, 320, 454, 10.1038/320454a0 · DOI · Paper page
  118. Rubanyi, 1986, Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor, Am. J. Physiol., 250, H822
  119. Motwani, 1998, Aortocoronary saphenous vein graft disease: pathogenesis, predisposition and prevention, Circulation, 97, 916, 10.1161/01.CIR.97.9.916 · DOI · Paper page
  120. Hunink, 1994, Pantency results of percutaneous and surgical revascularization for femoropopliteal arterial disease, Med. Decis. Making, 14, 71, 10.1177/0272989X9401400109 · DOI
  121. Mehta, 1997, Towards a solution for saphenous vein graft failure, Asia Pac. Heart J., 6, 107, 10.1016/S1328-0163(97)90004-X · DOI
  122. Davies, 1995, Pathophysiology of vein graft failure, Eur. J. Vasc. Endovasc. Surg., 9, 7, 10.1016/S1078-5884(05)80218-7 · DOI · Paper page
  123. Davies, 1994, Control of the structural and functional consequences of vein graft intimal hyperplasia with a 21-aminosteroid (U74389G), Eur. J. Vasc. Surg., 8, 448, 10.1016/S0950-821X(05)80964-8 · doi:10.1016/s0950-821x(05)80964-8
  124. Cox, 1991, Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries, Prog. Cardiovasc. Dis., 34, 45, 10.1016/0033-0620(91)90019-I · DOI · Paper page
  125. Piotrowski, 1991, Lipid peroxidation: a possible factor in late graft failure of coronary artery bypass grafts, J. Vasc. Surg., 13, 652, 10.1067/mva.1991.28085 · doi:10.1067/mva.1991.28085
  126. Crawford, 1991, Arterial wall oxygenation, oxyradicals, and atherosclerosis, Atherosclerosis, 89, 97, 10.1016/0021-9150(91)90049-9 · DOI · Paper page
  127. Halliwell, 1992, Free radicals, antioxidants and human disease: where are we now?, J. Lab. Clin. Med., 119, 598
  128. Yamakawa, 1989, Effects of polyethylene-modified superoxide dismutase on reperfusion induced arrhythmias in isolated rat and guinea pig hearts, J. Mol. Cell. Cardiol., 21, 441, 10.1016/0022-2828(89)90784-0 · doi:10.1016/0022-2828(89)90784-0
  129. Woodward, 1985, Effect of some free radical scavengers on reperfusion-induced arrhythmias in the isolated rat heart, J. Mol. Cell. Cardiol., 17, 485, 10.1016/S0022-2828(85)80053-5 · DOI · Paper page
  130. Bernier, 1986, Reperfusion-induced arrhythmias and oxygen-derived free radicals: studies with ‘anti-free radical’ interventions and a free radical-generating system in the isolated perfused rat heart, Circ. Res., 58, 331, 10.1161/01.RES.58.3.331 · DOI · Paper page
  131. Corr, 1983, Potential electrophysiologic mechanisms responsible for dysarrhythmias associated with reperfusion of ischemic myocardium, Circulation, 68, 16
  132. Goldberg, 1983, Reperfusion arrhythmia: a marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardium infarction, Am. Heart J., 105, 26, 10.1016/0002-8703(83)90274-0 · doi:10.1016/0002-8703(83)90274-0
  133. Robinson, 1984, Creatine phosphate: an additive myocardial protective and antiarrhythmic agent in cardioplegia, J. Thorac. Cardiovasc. Surg., 87, 190, 10.1016/S0022-5223(19)37413-6 · DOI
  134. Tzivoni, 1983, Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal’s angina, Am. Heart J., 105, 323, 10.1016/0002-8703(83)90534-3 · doi:10.1016/0002-8703(83)90534-3
  135. Garcia-Alves, 1989, Pretreatment with a single bolus injection of polyoxyethylene-modified superoxide dismutase prevents reperfusion induced arrhythmias in the anesthetized rat, Jpn. J. Pharmacol., 51, 199, 10.1254/jjp.51.199 · doi:10.1254/jjp.51.199
  136. Manning, 1984, Reperfusion-induced arrhythmias: mechanisms and prevention, J. Mol. Cell. Cardiol., 16, 497, 10.1016/S0022-2828(84)80638-0 · DOI · Paper page
  137. Tanaka, 1990, Evidence against the ‘early protection-delayed death’ hypothesis of superoxide dismutase therapy in experimental myocardial infarction, Circ. Res., 67, 636, 10.1161/01.RES.67.3.636 · DOI
  138. Werns, 1985, The independent effects of oxygen radical scavengers on canine infarct size. Reduction by superoxide dismutase but not catalase, Circ. Res., 56, 895, 10.1161/01.RES.56.6.895 · DOI · Paper page
  139. Naslund, 1986, Superoxide dismutase and catalase reduce infarct size in a porcine myocardial occlusion-reperfusion model, J. Mol. Cell. Cardiol., 18, 1077, 10.1016/S0022-2828(86)80294-2 · DOI
  140. Tamura, 1988, Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart, Circ. Res., 63, 944, 10.1161/01.RES.63.5.944 · DOI
  141. Tang, 1993, Polyethylene glycol-conjugate superoxide dismutase protects rats against oxygen toxicity, J. Appl. Physiol., 74, 1425, 10.1152/jappl.1993.74.3.1425 · doi:10.1152/jappl.1993.74.3.1425
  142. Witschi, 1981, Potentiation of diffuse lung damage by oxygen: determining variables, Am. Rev. Respir. Dis., 123, 98
  143. Fox, 1981, Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factor and polymorphonuclear leukocytes, Am. Rev. Respir. Dis., 123, 521
  144. Freeman, 1981, Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria, J. Biol. Chem., 256, 10986, 10.1016/S0021-9258(19)68544-3 · DOI · Paper page
  145. White, 1989, Polyethylene glycol-attached antioxidant enzymes decrease pulmonary oxygen toxicity in rats, J. Appl. Physiol., 66, 584, 10.1152/jappl.1989.66.2.584 · DOI
  146. Olson, 1985, Dexamethasone and indomethacin modify endotoxin-induced respiratory failure in pigs, J. Appl. Physiol., 58, 274, 10.1152/jappl.1985.58.1.274 · DOI
  147. Olson, 1987, Effect of polyethylene glycol–superoxide dismutase and catalase on endotoxemia in pigs, J. Appl. Physiol., 63, 1526, 10.1152/jappl.1987.63.4.1526 · DOI
  148. Suzuki, 1992, Polyethylene glycol-conjugated superoxide dismutase attenuates septic lung injury in guinea pigs, Am. Rev. Respir. Dis., 145, 388, 10.1164/ajrccm/145.2_Pt_1.388 · doi:10.1164/ajrccm/145.2_pt_1.388
  149. Fein, 1983, The risk factors, incidence, and prognosis of ARDS following septicemia, Chest, 83, 40, 10.1378/chest.83.1.40 · DOI · Paper page
  150. Villar, 1989, The incidence of the adult respiratory distress syndrome, Am. Rev. Respir. Dis., 140, 814, 10.1164/ajrccm/140.3.814 · DOI
  151. Babior, 1978, Oxygen-dependent microbial killing by phagocytes, New Engl. J. Med., 298, 659, 10.1056/NEJM197803232981205 · DOI · Paper page
  152. Shasby, 1982, Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: role of oxygen radicals, Am. Rev. Respir. Dis., 125, 443
  153. Cochrane, 1983, Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid, J. Clin. Invest., 71, 754, 10.1172/JCI110823 · DOI · Paper page
  154. Weiland, 1986, Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance, Am. Rev. Respir. Dis., 133, 218
  155. Mossman, 1986, Alteration of superoxide dismutase (SOD) activity in tracheal epithelial cells by asbestos and inhibition of cytotoxicity by antioxidants, Lab. Invest., 54, 204
  156. Shatos, 1987, Prevention of asbestos-induced cell death in rat lung fibroblasts and alveolar macrophages by scavengers of active oxygen species, Environ. Res., 44, 103, 10.1016/S0013-9351(87)80090-7 · DOI · Paper page
  157. Goodglick, 1986, Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages, Cancer Res., 46, 5558
  158. Hansen, 1987, Generation of superoxide (O2) from alveolar macrophages exposed to asbestiform and nonfibrous particles, Cancer Res., 47, 1681
  159. Case, 1986, Asbestos effects on superoxide production: an in vitro study of hamster alveolar macrophages, Environ. Res., 39, 299, 10.1016/S0013-9351(86)80056-1 · DOI
  160. Donaldson, 1984, Chemiluminescence of asbestos-activated macrophages, Br. J. Exp. Pathol., 65, 81
  161. He, 1993, Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia–reperfusion, Am. J. Physiol., 265, H252
  162. Kontos, 1986, Superoxide production in experimental brain injury, J. Neurosurg., 64, 803, 10.3171/jns.1986.64.5.0803 · DOI · Paper page
  163. Kontos, 1984, Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats, Circ. Res., 55, 295, 10.1161/01.RES.55.3.295 · DOI · Paper page
  164. Haun, 1991, Polyethylene glycol-conjugated superoxide dismutase fails to augment brain superoxide dismutase activity in piglets, Stroke, 22, 655, 10.1161/01.STR.22.5.655 · doi:10.1161/01.str.22.5.655
  165. Forsman, 1988, Superoxide dismutase and catalase failed to improve neurologic outcome after complete cerebral ischemia in the dog, Acta Anaesthesiol. Scand., 32, 152, 10.1111/j.1399-6576.1988.tb02705.x · DOI
  166. Kuroiwa, 1985, The biphasic opening of the blood–brain barrier to proteins following temporary middle cerebral artery occlusion, Acta Neuropathol., 68, 122, 10.1007/BF00688633 · DOI · Paper page
  167. Hatashita, 1990, Brain edema and cerebrovascular permeability during cerebral ischemia in rats, Stroke, 21, 582, 10.1161/01.STR.21.4.582 · DOI · Paper page
  168. Morpurgo, 1996, Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury, Transplantation, 62, 1221, 10.1097/00007890-199611150-00006 · doi:10.1097/00007890-199611150-00006
  169. Hoshino, 1988, Ablation of free-radical mediated reperfusion injury for the salvage of kidneys taken from non-heartbeating donors, Transplantation, 45, 284, 10.1097/00007890-198802000-00006 · DOI
  170. Heberer, 1991, Protective effect of allopurinol and superoxide dismutase in renal isografts in cyclosporin A-treated rats, Ren. Fail., 13, 233, 10.3109/08860229109022159 · DOI
  171. Winchell, 1989, Lack of effect of oxygen-radical scavenging systems in the preserved reperfused rabbit kidney, Transplantation, 48, 393, 10.1097/00007890-198909000-00007 · doi:10.1097/00007890-198909000-00007
  172. Pollak, 1993, A randomized double-blind trial of the use of human recombinant superoxide dismutase in renal transplantation, Transplantation, 55, 57, 10.1097/00007890-199301000-00011 · doi:10.1097/00007890-199301000-00011
  173. Land, 1994, The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants, Transplantation, 57, 211, 10.1097/00007890-199401001-00010 · DOI · Paper page
  174. Galinanes, 1992, PEG–SOD and myocardial protection, Circulation, 86, 672, 10.1161/01.CIR.86.2.672 · doi:10.1161/01.cir.86.2.672
  175. Zimmerman, 1992, Reperfusion injury, Surg. Clin. North Am., 72, 65, 10.1016/S0039-6109(16)45628-8 · DOI · Paper page
  176. Toledo-Pereira, 1994, Neutrophils, cytokines, and adhesion molecules in hepatic ischemia and reperfusion injury, J. Am. Coll. Surg., 179, 758
  177. Atalla, 1985, Influence of oxygen-derived free radical scavengers on ischemic livers, Transplantation, 40, 584, 10.1097/00007890-198512000-00002 · DOI · Paper page
  178. Rauen, 1994, The potential role of reactive oxygen species in liver ischemia/reperfusion injury following liver surgery, Hepato-Gastroenterology, 41, 333
  179. Esterbauer, 1991, Determination of aldehydic lipid peroxidation products: malonaldehyde and hydroxymonenal, Vol. 186B, 407
  180. Draper, 1991, Malonaldehyde determination as index of lipid peroxidation, Vol. 186B, 421

Cited by

See all 273

Metadata

Authors
Veronese, F. M., Caliceti, P., Schiavon, O., & Sergi, M.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2002-06
Volume
54
Issue
4
Pages
587-606
ISSN
0169-409X (ISSN-L)
OpenAlex
W2036378709
Cited by
273
References
3
FWCI
0.61
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polyethylene glycol–superoxide dismutase, a conjugate in search of exploitation. https://app.cochat.ai/papers/10.1016/s0169-409x(02)00029-7
The paper
Veronese, F. M., Caliceti, P., Schiavon, O., & Sergi, M. (2002). Polyethylene glycol–superoxide dismutase, a conjugate in search of exploitation. Advanced Drug Delivery Reviews. https://doi.org/10.1016/s0169-409x(02)00029-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.